Dennis Podlesak Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Dennis Podlesak.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Dennis Podlesak. Dennis Podlesak is a Director in AVANIR PHARMACEUTICALS, INC. ($AVNR) and a Director in Alliqua BioMedical, Inc. ($ALQA) and a Director in Tobira Therapeutics, Inc. ($TBRA) and a in Syndax Pharmaceuticals Inc ($SNDX).
Address: 11388 SORRENTO VALLEY ROAD, SUTIE 200 SAN DIEGO 92121 CA
Companies in which Dennis Podlesak is an Insider
Adynxx, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Dennis Podlesak: Director
Holdings: 85,254 shares
Current Value: $46,890
Latest Transaction: May 07 2019
$ALQA Market Capitalization: $17.78M
$ALQA Previous Close: $0.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVANIR PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dennis Podlesak: Director
Holdings: 7,435 shares
Latest Transaction: Jun 02 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syndax Pharmaceuticals Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dennis Podlesak:
Holdings: 43,300 shares
Current Value: $376,277
Latest Transaction: Apr 22 2021
$SNDX Market Capitalization: $163.37M
$SNDX Previous Close: $8.69
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tobira Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Dennis Podlesak: Director
Holdings: 0 shares
Latest Transaction: Nov 03 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Dennis Podlesak
Sentiment: All, ALQA, AVNR, SNDX, TBRA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | SNDX | Syndax Pharmaceuti ... | Podlesak Dennis | Buy | P | 14.11 | 13,967 | 197,077 | 43,300 | 29.3 K to 43.3 K (+47.62 %) | |
| Feb 14 2020 | SNDX | Syndax Pharmaceuti ... | Podlesak Dennis | Option Exercise | A | 9.47 | 44,000 | 416,680 | 44,000 | ||
| Jun 12 2019 | SNDX | Syndax Pharmaceuti ... | Podlesak Dennis | Option Exercise | A | 7.88 | 44,000 | 346,720 | 44,000 | ||
| May 07 2019 | ALQA | Alliqua BioMedical ... | Podlesak Dennis | Director | Option Exercise | A | 3.06 | 55,879 | 170,990 | 55,879 | |
| May 07 2019 | ALQA | Alliqua BioMedical ... | Podlesak Dennis | Director | Option Exercise | A | 1.39 | 396 | 550 | 396 | |
| May 07 2019 | ALQA | Alliqua BioMedical ... | Podlesak Dennis | Director | Grant | A | 0.00 | 85,254 | 0 | 85,254 | 0 to 85.3 K |
| May 25 2018 | SNDX | Syndax Pharmaceuti ... | Podlesak Dennis | Option Exercise | A | 8.93 | 14,000 | 125,020 | 14,000 |